Literature DB >> 1733935

Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.

D A Engler1, S R Campion, M R Hauser, J S Cook, S K Niyogi.   

Abstract

In a preliminary study we demonstrated that the formation of the epidermal growth factor (EGF) receptor-ligand complex requires the participation of the highly conserved arginine 41 side chain of the growth factor peptide (Engler, D.A., Montelione, G.T., and Niyogi, S.K. (1990) FEBS Lett. 271, 47-50). In an attempt to gain further insight into the nature of this interaction(s), we used both site-directed mutagenesis and chemical modification reagents to produce human EGF (hEGF) analogues with altered chemical properties of the residue 41 side chain. Eight mutant analogues of hEGF were generated, substituting arginine 41 with lysine, glutamine, isoleucine, tyrosine, glycine, alanine, aspartate, or glutamate. Although each of the mutant analogues was able to displace wild-type hEGF fully in receptor competition binding assays, affinity of the receptor for the mutants was substantially reduced, varying from 0.4 to less than 0.01% of that observed for wild-type growth factor. At sufficiently high concentrations these mutants were able to stimulate DNA synthesis in mouse keratinocytes. Substitution of lysine for arginine 41 reduced the receptor affinity 250-fold from that observed for wild type, despite retention of the positive electrostatic charge. The lysine substitution leaves a reactive amine at position 41 and made it possible, using amine-specific chemical modification reagents, to produce selected arginine homologues that were tested for their effects on receptor binding, receptor tyrosine kinase activation, and stimulation of DNA synthesis in mouse keratinocytes. The reaction of lysine 41 with methyl acetimidate resulted in a lysineacetamidine product which only partially restored activity of the lysine hEGF mutant. However, reaction with O-methylisourea resulted in generation of an arginine 41 homologue (homoarginine) which restored full activity. The results indicate that the chemical properties inherent in the guanidinium group of the arginine 41 side chain of hEGF are responsible for optimal receptor-ligand association.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733935

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

2.  Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5: STRUCTURAL, FUNCTIONAL, AND MOLECULAR DYNAMICS SIMULATION ANALYSES.

Authors:  Yuji Kado; Eiichi Mizohata; Satoru Nagatoishi; Mariko Iijima; Keiko Shinoda; Takamitsu Miyafusa; Taisuke Nakayama; Takuma Yoshizumi; Akira Sugiyama; Takeshi Kawamura; Young-Hun Lee; Hiroyoshi Matsumura; Hirofumi Doi; Hideaki Fujitani; Tatsuhiko Kodama; Yoshikazu Shibasaki; Kouhei Tsumoto; Tsuyoshi Inoue
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

3.  A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage.

Authors:  C Souriau; P Fort; P Roux; O Hartley; M P Lefranc; M Weill
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

4.  The structure of the FnI-EGF-like tandem domain of coagulation factor XII solved using SIRAS.

Authors:  D X Beringer; L M J Kroon-Batenburg
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-26

5.  Combined use of 13C chemical shift and 1H alpha-13C alpha heteronuclear NOE data in monitoring a protein NMR structure refinement.

Authors:  B Celda; C Biamonti; M J Arnau; R Tejero; G T Montelione
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

6.  Chemical modulation of the chaperone function of human alphaA-crystallin.

Authors:  Ashis Biswas; Shawn Lewis; Benlian Wang; Masaru Miyagi; Puttur Santoshkumar; Mahesha H Gangadhariah; Ram H Nagaraj
Journal:  J Biochem       Date:  2008-03-15       Impact factor: 3.387

7.  Regeneration of catalytic activity of glutamine synthetase mutants by chemical activation: exploration of the role of arginines 339 and 359 in activity.

Authors:  A M Dhalla; B Li; M F Alibhai; K J Yost; J M Hemmingsen; W M Atkins; J Schineller; J J Villafranca
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

8.  A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF.

Authors:  Shuji Sato; Andrew W Drake; Isamu Tsuji; Jinhong Fan
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Molecular determinants of epidermal growth factor binding: a molecular dynamics study.

Authors:  Jeffrey M Sanders; Matthew E Wampole; Mathew L Thakur; Eric Wickstrom
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.

Authors:  Hannes H Loeffler; Martyn D Winn
Journal:  Proteins       Date:  2013-08-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.